"Virus Activation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The mechanism by which latent viruses, such as genetically transmitted tumor viruses (PROVIRUSES) or PROPHAGES of lysogenic bacteria, are induced to replicate and then released as infectious viruses. It may be effected by various endogenous and exogenous stimuli, including B-cell LIPOPOLYSACCHARIDES, glucocorticoid hormones, halogenated pyrimidines, IONIZING RADIATION, ultraviolet light, and superinfecting viruses.
| Descriptor ID |
D014775
|
| MeSH Number(s) |
G06.920.925.940
|
| Concept/Terms |
Virus Activation- Virus Activation
- Activation, Virus
- Activations, Virus
- Virus Activations
- Viral Activation
- Activation, Viral
- Activations, Viral
- Viral Activations
- Virus Induction
- Induction, Virus
- Inductions, Virus
- Virus Inductions
Prophage Induction- Prophage Induction
- Induction, Prophage
- Inductions, Prophage
- Prophage Inductions
Prophage Excision- Prophage Excision
- Excision, Prophage
- Excisions, Prophage
- Prophage Excisions
|
Below are MeSH descriptors whose meaning is more general than "Virus Activation".
Below are MeSH descriptors whose meaning is more specific than "Virus Activation".
This graph shows the total number of publications written about "Virus Activation" by people in this website by year, and whether "Virus Activation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2015 | 1 | 2 | 3 |
| 2017 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Virus Activation" by people in Profiles.
-
Hepatitis B reactivation in patients on biologics: A perfect storm. J Am Acad Dermatol. 2022 01; 86(1):37-38.
-
Hepatitis B Virus Reactivation: Risk Factors and Current Management Strategies. Pharmacotherapy. 2019 12; 39(12):1190-1203.
-
Radiotherapy-induced reactivation of neurotrophic human herpes viruses: Overview and management. J Clin Virol. 2018 01; 98:18-27.
-
Screening for viral hepatitis prior to rituximab chemotherapy. Ann Hematol. 2016 Jan; 95(1):27-33.
-
Reactivation of latent HIV-1 provirus via targeting protein phosphatase-1. Retrovirology. 2015 Jul 16; 12:63.
-
NK Cell and Ig Interplay in Defense against Herpes Simplex Virus Type 1: Epistatic Interaction of CD16A and IgG1 Allotypes of Variable Affinities Modulates Antibody-Dependent Cellular Cytotoxicity and Susceptibility to Clinical Reactivation. J Immunol. 2015 Aug 15; 195(4):1676-84.
-
Epstein-Barr virus reactivation and hemophagocytic lymphohistiocytosis in a patient with chronic lymphocytic leukemia. Leuk Lymphoma. 2014 Dec; 55(12):2938-41.
-
Pharmacovigilance and PML in the oncology setting. Cleve Clin J Med. 2011 Nov; 78 Suppl 2:S13-7.
-
Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis. Am J Hematol. 2010 Aug; 85(8):627-9.
-
Role of micro-RNAs in regulation of lentiviral latency and persistence. Appl Immunohistochem Mol Morphol. 2006 Sep; 14(3):276-90.